In animal models of ALS, Guanabenz, that is commonly used to treat hypertension, has been identified to induce eIF2α dephosphorylation and persistent activity of the ISR, allowing the clearance of misfolded proteins and prolonging motor neurons survival [188]. This evidence concerns the gene EIF2A and amyotrophic lateral sclerosis.